United Therapeutics Reports Strong Q3 2024 Results
United Therapeutics Corp. ( (UTHR) ) has realeased its Q3 earnings. Here is a breakdown of the information United Therapeutics Corp. presented ...
Zacks.com on MSN10d
United Therapeutics Q3 Earnings & Sales Beat Estimates
United Therapeutics’ UTHR third-quarter 2024 earnings of $6.39 per share beat the Zacks Consensus Estimate of $6.18. Earnings ...
Houston Chronicle12d
United Therapeutics: Q3 Earnings Snapshot
SILVER SPRING, Md. (AP) — SILVER SPRING, Md. (AP) — United Therapeutics Corp. (UTHR) on Wednesday reported third-quarter earnings of $309.1 million. The Silver Spring, Maryland-based company ...
Pallas Capital Advisors LLC Grows Position in United Therapeutics Co. (NASDAQ:UTHR)
Pallas Capital Advisors LLC raised its holdings in United Therapeutics Co. (NASDAQ:UTHR – Free Report) by 62.5% during the ...
CRISPR Therapeutics Provides Business Update and Reports Third Quarter 2024 Financial Results
CASGEVY™ approved for the treatment of patients 12 years of age and older with sickle cell disease (SCD) and transfusion-dependent beta ...
United Therapeutics: Q3 Earnings Snapshot
SILVER SPRING, Md. (AP) — SILVER SPRING, Md. (AP) — United Therapeutics Corp. (UTHR) on Wednesday reported third-quarter earnings of $309.1 million. The Silver Spring, Maryland-based company said it ...